EPHX2 and metabolic dysfunction-associated steatotic liver disease: Overall these results suggest that while obesity is associated with overall reduced fatty acid diols, obesity-associated WAT inflammation and the severity of MASLD are associated with dampened sEH activity (Fig. 7c).